121 results
8-K
EX-10.1
APVO
Aptevo Therapeutics Inc
15 Apr 24
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
4:17pm
to evidence the accuracy of any of the representations and warranties, or the satisfaction of any of the conditions or agreements, herein contained.
If any
8-K
EX-99.1
APVO
Aptevo Therapeutics Inc
15 Apr 24
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
4:17pm
limitation, statements regarding the completion, timing, size and use of proceeds of the public offering, the satisfaction of customary closing conditions … statements, including a deterioration in Aptevo's business or prospects; uncertainties related to market conditions, the satisfaction of customary
8-K
EX-4.1
APVO
Aptevo Therapeutics Inc
15 Apr 24
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
4:17pm
) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares
8-K
EX-4.2
APVO
Aptevo Therapeutics Inc
15 Apr 24
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
4:17pm
transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder
8-K
EX-10.2
rnyo64 59o7c9m
15 Apr 24
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
4:17pm
424B4
xxav5u589wh
12 Apr 24
Prospectus supplement with pricing info
5:23pm